SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-01-503073
Filing Date
2001-10-12
Accepted
2001-10-12 00:00:00
Documents
5
Period of Report
2001-10-12
Items
Item 7: Financial statements and exhibits
Item 9: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS b40759ape8-k.htm 8-K 9353
3 EX-99.1 PRESS RELEASE DATED OCTOBER 12, 2001 b40759apex99-1.htm EX-99.1 9646
4 PDF COPY OF PRESS RELEASE DATED OCTOBER 12, 2001 b40759apex99-1pdf.pdf EX-99.1 94524
5 ARIAD PHARMACEUTICALS 8-K IN PDF FORMAT b40759ape8-k_pdf.pdf 8-K 35177
6 GRAPHIC b40759apariad.gif GRAPHIC 2495
  Complete submission text file 0000950135-01-503073.txt   152899
Mailing Address 26 LANDSDOWNE 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-76414 | Film No.: 1757481
SIC: 2836 Biological Products, (No Diagnostic Substances)